Median Diagnostics Inc. (XKON: 233250)

Median Diagnostics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2016	FY 2015
Period Ending	Dec 31, 2016	Dec 31, 2016	Dec 31, 2015
Operating Revenue	7,861	7,861	5,598
Other Revenue	-0	-0	-
Revenue	7,861	7,861	5,598
Revenue Growth (YoY)	-	40.43%	-
Cost of Revenue	2,908	2,908	1,846
Gross Profit	4,953	4,953	3,752
Selling, General & Admin	1,870	1,870	1,332
Research & Development	1,607	1,607	1,253
Other Operating Expenses	31.08	31.08	19.46
Operating Expenses	3,786	3,786	3,035
Operating Income	1,168	1,168	716.64
Interest Expense	-390.56	-390.56	-95.51
Interest & Investment Income	60.06	60.06	31.11
Currency Exchange Gain (Loss)	21.57	21.57	26.27
Other Non Operating Income (Expenses)	-2,082	-2,082	37.55
EBT Excluding Unusual Items	-1,223	-1,223	716.06
Gain (Loss) on Sale of Assets	49.7	49.7	-
Asset Writedown	-	-	-158.32
Pretax Income	-1,173	-1,173	557.73
Income Tax Expense	-605.69	-605.69	-212.5
Net Income	-567.58	-567.58	770.23
Net Income to Common	-567.58	-567.58	770.23
Shares Outstanding (Basic)	1	1	1
Shares Outstanding (Diluted)	1	1	1
Shares Change (YoY)	-	-7.59%	-
EPS (Basic)	-496.00	-496.00	640.00
EPS (Diluted)	-496.00	-496.00	622.00
Free Cash Flow	-1,413	-1,413	1,477
Free Cash Flow Per Share	-1235.02	-1235.02	1192.83
Gross Margin	63.01%	63.01%	67.02%
Operating Margin	14.86%	14.86%	12.80%
Profit Margin	-7.22%	-7.22%	13.76%
Free Cash Flow Margin	-17.98%	-17.98%	26.39%
EBITDA	1,592	1,592	1,098
EBITDA Margin	20.25%	20.25%	19.61%
D&A For EBITDA	424.18	424.18	381.11
EBIT	1,168	1,168	716.64
EBIT Margin	14.86%	14.86%	12.80%
Advertising Expenses	50.36	50.36	84.85

Source: S&P Capital IQ. Standard template. Financial Sources.